The test measures two proteins that are linked to amyloid plaques in the brain, which are among the hallmarks of Alzheimer's.

Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...

The new test, known as the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, detects amyloid plaques through blood testing, a ...

U.S. regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...

The test would help identify patients who may benefit from drugs that can modestly slow the memory-destroying disease.

The FDA said the results of the newly cleared blood test must be assessed in conjunction with other clinical information from ...

The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment ...

The FDA has approved the first blood test to help detect Alzheimer’s disease. Developed by Fujirebio Diagnostics, the ...

The FDA has approved the Lumipulse Plasma Ratio test, a groundbreaking blood test for early dementia detection. This less ...

The Food and Drug Administration has approved the first blood test for diagnosing Alzheimer's disease, the agency announced ...

US regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...

The US on Friday approved the first blood test for Alzheimer's, a move that can help patients begin treatment earlier with ...